See the DrugPatentWatch profile for ozempic

Ozempic, also known as semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to regulate blood sugar levels in people with type 2 diabetes. It works by mimicking the functions of natural GLP-1 hormones in the body, which are involved in regulating blood sugar levels and appetite.

One of the ways Ozempic regulates carbohydrate breakdown is by slowing down the rate at which the stomach empties after eating. This leads to a more gradual absorption of glucose into the bloodstream, which helps to prevent spikes in blood sugar levels.

Additionally, Ozempic increases the body's insulin production in response to meals, which helps to promote the uptake and utilization of glucose by cells. At the same time, it decreases the release of glucagon, a hormone that increases blood sugar levels by promoting the release of glucose from the liver.

Furthermore, Ozempic has been shown to reduce appetite and promote weight loss, which can also help to improve blood sugar control in people with type 2 diabetes.

It is important to note that while Ozempic can help to regulate carbohydrate breakdown and improve blood sugar control, it is not a substitute for a healthy lifestyle. Regular exercise, a balanced diet, and other lifestyle modifications are still important for managing type 2 diabetes.

Sources:

1. <https://www.drugpatentwatch.com/drugs/ozempic>
2. <https://www.ncbi.nlm.nih.gov/books/NBK538153/>
3. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364572/>
4. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801687/>